Norges Bank’s NextCure NXTC Stock Holding History

Norges Bank’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,325	Closed	-$76.8K	–	2083
2023 Q1	$76.8K	Hold	4,325	–	–	﹤0.01%	2086
2022 Q4	$73.2K	Hold	4,325	–	–	﹤0.01%	2127
2022 Q3	$143K	Hold	4,325	–	–	﹤0.01%	2083
2022 Q2	$244K	Hold	4,325	–	–	﹤0.01%	2033
2022 Q1	$252K	Hold	4,325	–	–	﹤0.01%	2132
2021 Q4	$311K	Hold	4,325	–	–	﹤0.01%	2170
2021 Q3	$350K	Sell	4,325 -75	-2%	-$6.58K	﹤0.01%	2237
2021 Q2	$424K	Sell	4,400 -13,871	-76%	-$1.42M	﹤0.01%	2167
2021 Q1	$2.19M	Buy	+18,271	New	+$2.65M	﹤0.01%	1989

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Norges Bank's NXTC Position: Q2 2023 in Review

Norges Bank sold out of NextCure (NXTC) in Q2 2023, closing a stake of 4,325 shares — an estimated $76.8K sold.

Norges Bank first reported a position in NXTC in Q1 2021 and held it in 9 quarters. The position peaked at $2.19M in Q1 2021. 43 funds tracked by Wall St. Rank hold NXTC as of Q2 2023.

Norges Bank reported no remaining NextCure position as of Q2 2023 after selling out during the quarter.
Norges Bank sold 4,325 NextCure shares in Q2 2023, an estimated $76.8K.
Norges Bank first reported a position in NextCure in Q1 2021 and held it in 9 quarters.
Norges Bank's NextCure position peaked at $2.19M in Q1 2021.
43 funds tracked by Wall St. Rank held NextCure as of Q2 2023.

Based on Norges Bank's 13F filing for Q2 2023, filed 14 Aug 2023.